FLAGSHIP PIONEERING, INC.
Adviser information for FLAGSHIP PIONEERING, INC. last updated from Form ADV on March 29th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Corporation |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 0 |
|---|---|
| Investment Advisory/Research | 0 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | No |
|---|
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 0 | $0 |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 0 |
Services
| Advisory Services | – |
|---|---|
| Compensation | – |
Principal Office
55 CAMBRIDGE PARKWAYSUITE 800E
CAMBRIDGE
MA
United States
Monday - Friday, 8:00AM - 5:00PM
Tel: 617-868-1888, Fax: 617-868-1115
Chief Compliance Officer
NoneIndustry Affiliates
| ET FUND GENERAL PARTNER | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP LABS VII MANAGER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP PIONEERING FUND VII GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP PIONEERING FUND VIII GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP PIONEERING SPECIAL OPPORTUNITIES FUND II GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP VENTURELABS V MANAGER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP VENTURELABS VI MANAGER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP VENTURES GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FPA GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| FPN GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
| NEWCOGEN GROUP, INC. | Sponsor, GP, manager of pooled investment vehicles |
| NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| ET FUND | Venture Capital Fund | $280.0M | $140.0M | 3 |
| FLAGSHIP LABS VII LLC | Venture Capital Fund | $107.2M | $0.0M | 248 |
| FLAGSHIP PIONEERING FUND VI, L.P. | Venture Capital Fund | $2,107.8M | $0.2M | 45 |
| FLAGSHIP PIONEERING FUND VII, L.P. | Venture Capital Fund | $3,418.3M | $1.0M | 119 |
| FLAGSHIP PIONEERING FUND VIII, L.P. | Venture Capital Fund | $1,460.1M | $0.5M | 69 |
| FLAGSHIP PIONEERING SPECIAL OPPORTUNITIES FUND II, L.P. | Venture Capital Fund | $855.4M | $0.5M | 61 |
| FLAGSHIP V VENTURELABS RX FUND, L.P. | Venture Capital Fund | $11.8M | $50.0M | 2 |
| FLAGSHIP VENTURELABS IV LLC | Venture Capital Fund | $12.8M | $0.0M | 13 |
| FLAGSHIP VENTURELABS V LLC | Venture Capital Fund | $251.3M | $0.0M | 94 |
| FLAGSHIP VENTURELABS VI LLC | Venture Capital Fund | $1,575.4M | $0.0M | 182 |
| FLAGSHIP VENTURES CNYELSF FUND, L.P. | Venture Capital Fund | $23.9M | $7.5M | 4 |
| FLAGSHIP VENTURES FUND 2004, L.P. | Venture Capital Fund | $0.2M | $0.1M | 33 |
| FLAGSHIP VENTURES FUND 2007, L.P. | Venture Capital Fund | $23.2M | $0.1M | 35 |
| FLAGSHIP VENTURES FUND IV-RX, L.P. | Venture Capital Fund | $158.4M | $30.0M | 2 |
| FLAGSHIP VENTURES FUND IV, L.P. | Venture Capital Fund | $816.1M | $0.3M | 31 |
| FLAGSHIP VENTURES FUND V, L.P. | Venture Capital Fund | $488.5M | $0.3M | 39 |
| FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P. | Venture Capital Fund | $167.9M | $0.3M | 27 |
| FLAGSHIP VENTURES V AGRICULTURAL FUND, L.P. | Venture Capital Fund | $183.8M | $25.0M | 2 |
| FPA, L.P. | Venture Capital Fund | $249.7M | $2.5M | 3 |
| FPN II, L.P. | Venture Capital Fund | $254.8M | $2.5M | 3 |
| FPN III, L.P. | Venture Capital Fund | $349.9M | $3.5M | 3 |
| FPN, L.P. | Venture Capital Fund | $140.5M | $1.5M | 3 |
| NUTRITIONAL HEALTH DISRUPTIVE INNOVATION FUND, L.P. | Venture Capital Fund | $53.3M | $85.0M | 2 |
| NUTRITIONAL HEALTH LTP FUND, L.P. | Venture Capital Fund | $249.0M | $140.0M | 2 |
| NUTRITIONAL HEALTH SIDE FUND, L.P. | Venture Capital Fund | $0.2M | $20.0M | 2 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| AFEYAN, NOUBAR, B | Individual | – | CEO & PRESIDENT | 10/2001 | > 75% |
| CARELLI, CHARLES, ROBERT | Individual | – | CFO | 10/2012 | < 5% |
No. Employees, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| Foghorn Therapeutics Inc | COM | 54M | 9M | 1,3 |
| Foghorn Therapeutics Inc | COM | 19M | 3M | Noubar Afeyan |
| Moderna Inc | COM | 550M | 5M | 2,3 |
| Moderna Inc | COM | 466K | 4K | Noubar Afeyan |
| Omega Therapeutics Inc | COM | 14M | 7M | 1,3 |
| Omega Therapeutics Inc | COM | 46M | 22M | Noubar Afeyan |
| Sana Biotechnology Inc | COM | 50M | 9M | 1,3 |
| Sana Biotechnology Inc | COM | 87M | 16M | Noubar Afeyan |
| Seres Therapeutics Inc | COM | 6M | 8M | 2,3 |
| Seres Therapeutics Inc | COM | 11M | 15M | Noubar Afeyan |
| Syros Pharmaceuticals Inc | COM | 2M | 294K | 2,3 |
| Syros Pharmaceuticals Inc | COM | 5M | 1M | Noubar Afeyan |